Company Filing History:
Years Active: 2017
Title: The Innovative Mind of Weihua Hao: A Contributor to Parkinson's Disease Treatment
Introduction: Weihua Hao, a talented inventor based in Taipei, Taiwan, has made a significant contribution to the medical field with his innovative approach to treating Parkinson's disease. With a focus on creating effective pharmaceutical compositions, Hao represents the forefront of pharmaceutical research and development.
Latest Patents: Weihua Hao holds a patent for a pharmaceutical composition specifically designed for treating Parkinson's disease. This groundbreaking formulation includes levodopa, carbidopa, and entacapone, or their pharmaceutically acceptable salts. Notably, the innovation lies in the separation of entacapone from the mixture of levodopa and carbidopa, showcasing a unique preparation method that involves forming distinct particles for each component before tablet compression.
Career Highlights: Hao is associated with Innopharmax, Inc., a company that specializes in pharmaceutical development. His work emphasizes the importance of research in creating novel therapies for neurodegenerative diseases, particularly Parkinson's disease.
Collaborations: In his professional journey, Weihua Hao has collaborated with distinguished colleagues, including Jongjing Wang and Huiyun Chen. Their teamwork signifies a collective effort towards enhancing treatment options for patients affected by Parkinson's disease.
Conclusion: Weihua Hao's contributions to the field of pharmaceuticals through his innovative patent highlight the potential for advancements in treating complex medical conditions. As the research landscape evolves, inventors like Hao play a crucial role in transforming scientific insights into practical solutions for improving health outcomes.